FENCNasdaq United States
Market cap
$403.814 M
$11.58 +6.78%
Close of 7 Aug 2026
Revenue
$44.6M
#2779 by revenue
Earnings
-$9.74B
Loss-making
Shares outstanding
34,475,178
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Fennec Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.